Concepedia

Bo Cheng

BC

12

Publications

522

Citations

12

H-Index

2005

Active since

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Guangzhou University of Chinese Medicine

Wuhan University

Zhejiang Cancer Hospital

The University of Texas Southwestern Medical Center

Bo Cheng is an author at First Affiliated Hospital of Zhengzhou University specializing in medicine, immunology, and pathology.

ORCID

Top concepts

Publications per year

2005–2021

12

Publications

12

LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway

Bo Cheng, Aimei Rong, Quanbo Zhou et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 170 citations · Full text

Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1

Bo Cheng, Weihang Gao, Xiaojie Wu et al. · Journal of Agricultural and Food Chemistry · 2020 · 59 citations

, , +16

MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo

Bo Cheng, Qiaofang Wang, Yaodong Song et al. · Scientific Reports · 2020 · 44 citations · Full text

The inhibitory effect of human DEFA5 in growth of gastric cancer by targeting BMI1

Zhong-Wei Wu, Zhaohui Ding, Bo Cheng et al. · Cancer Science · 2021 · 40 citations · Full text

, , +21

MIF inhibitor ISO-1 alleviates severe acute pancreatitis-associated acute kidney injury by suppressing the NLRP3 inflammasome signaling pathway

Yanyan Liu, Yanna Liu, Qiaofang Wang et al. · International Immunopharmacology · 2021 · 38 citations

, , +10

Rows per page

1–5 of 12